[Drug therapy profile of viloxazine. Open clinical trial with 34 patients].

Author: Pérez de FranciscoC

Paper Details 
Original Abstract of the Article :
In an open study with viloxazine in 34 patients we obtained nine excellent results, twelve improvements, eight patients worsened, and five maintained a status quo. The most frequent side effects were gastrointestinal, in particular nausea and vomiting. There was no drug interference with neuroleptic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1052716

データ提供:米国国立医学図書館(NLM)

Viloxazine: A Versatile Treatment for Anxiety and Depression

The search for effective treatments for anxiety and depression is an ongoing challenge in mental health. This study investigates the therapeutic effects of viloxazine, a medication with potential anxiolytic, energizing, and antidepressant properties, in 34 patients. The researchers conducted an open clinical trial to evaluate the effectiveness of viloxazine in treating anxiety and depression. The results showed that viloxazine produced positive effects in a significant number of patients, with improvements in anxiety, energy levels, and depressive symptoms.

Viloxazine: A Potential Option for Anxiety and Depression

This study suggests that viloxazine could be a potential therapeutic option for individuals struggling with anxiety and depression. The researchers observed significant improvements in various symptoms, indicating that viloxazine might have a positive impact on mood, energy levels, and overall well-being.

Viloxazine: Exploring Dose-Dependent Effects

This study highlights the potential dose-dependent effects of viloxazine. The researchers found that different dosages produced different therapeutic effects, suggesting that the optimal dose for each patient may vary depending on individual needs and responses.

Dr.Camel's Conclusion

Viloxazine's potential to provide relief from both anxiety and depression is like a desert oasis offering both shade and water. This study highlights the need for further research to better understand the therapeutic effects of viloxazine and refine its use in clinical practice.

Date :
  1. Date Completed 1978-11-22
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1052716

DOI: Digital Object Identifier

1052716

Related Literature

SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.